Health Management Associates (NYSE: HMA) is expected to report Q2 earnings on July 23. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Health Management Associates' revenue will increase 15.4% and EPS will shrink 0.0%.

The average estimate for revenue is $1.61 billion. On the bottom line, the average EPS estimate is $0.20.

Revenue details
Last quarter, Health Management Associates reported revenue of $1.69 billion. GAAP reported sales were 18% higher than the prior-year quarter's $1.43 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.24. GAAP EPS of $0.14 for Q1 were 36% lower than the prior-year quarter's $0.22 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 47.0%, 50 basis points better than the prior-year quarter. Operating margin was 9.6%, 80 basis points worse than the prior-year quarter. Net margin was 2.2%, 170 basis points worse than the prior-year quarter.

Looking ahead
The full year's average estimate for revenue is $6.56 billion. The average EPS estimate is $0.89.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 218 members out of 257 rating the stock outperform, and 39 members rating it underperform. Among 78 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 68 give Health Management Associates a green thumbs-up, and 10 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Health Management Associates is outperform, with an average price target of $9.88.